Bacterin International

Board Description

Bacterin (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth.

Industry
Biotechnology
Country
United States
State
Montana
Stock Market
NYSE